DTU
DTU

Conference abstracts (11 of 182)

Years :

Search conference abstracts :

2005

41st Annual Meeting of the European Association for the Study of Diabetes, Athens
Obesity is a major determinant of the association of C-reactive protein levels with the number of metabolic syndrome components in recently diagnosed, drug-naive type 2 diabetes: the ADOPT study cohort
Kahn SE, Zinman B, Viberti G, Kravitz BG, Yu D, Heise MA, Freed MI, the ADOPT Study Group
Diabetologia 2005;48:suppl 1:A249
[Abstract]

41st Annual Meeting of the European Association for the Study of Diabetes, Athens
BMI and ratio of triglycerides to HDL are most predictive of insulin resistance in a drug naive population with type 2 diabetes
Patwardhan R, Lin X, Zambanini A, Eslava S, the ADOPT Study Group
Diabetologia 2005;48:suppl 1:A222
[Abstract]

65th Scientific Sessions of the American Diabetes Association, San Diego
Hepatic enzymes are associated with insulin resistance and impaired fibrinolysis in drug naïve, recently diagnosed type 2 diabetes subjects
Haffner SM, Kahn SE, Heise MA, O'Neill MC, Zinman B, the ADOPT Study Group
Diabetes 2005;54:suppl 1:A255
[Abstract]

65th Scientific Sessions of the American Diabetes Association, San Diego
Obesity is a major determinant of the association of C-reactive protein levels with the number of metabolic syndrome components in type 2 diabetes
Kahn SE, Zinman B, Viberti G, Kravitz BG, Yu D, Heise MA, Freed MI, the ADOPT Study Group
Diabetes 2005;54:suppl 1:A255
[Abstract]

65th Scientific Sessions of the American Diabetes Association, San Diego
A Cardiovascular Risk Calculator for Type 2 Diabetes
Coleman RL, Stevens RJ, Matthews DR, Holman RR
Diabetes 2005;54:Suppl 1:A172

41st Annual Meeting of the European Association for the Study of Diabetes, Athens
Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation
Coleman RL, Stevens RJ, Holman RR
Diabetologia 2005;48:Suppl 1:A32

41st Annual Meeting of the European Association for the Study of Diabetes, Athens
FPG and HbA1c are independent risk factors for microvascular but not macrovascular complications in newly diagnosed type 2 diabetes
Kim JI, Stevens RJ, Holman RR
Diabetologia 2005;48:Suppl 1:A33
[Abstract]

41st Annual Meeting of the European Association for the Study of Diabetes, Athens
Susceptibility for latent autoimmune diabetes in adults (LADA) is determined by variation at the IDDM2 (insulin-gene) locus in white Caucasian patients from UK repositories
Desai M, Zeggini E, Owen KR, Holman RR, Levy JC, Hattersley AT, Hitman GA, Walker M, McCarthy MI, Clark A
Diabetologia 2005;48:Suppl1:A86
[Abstract]

41st Annual Meeting of the European Association for the Study of Diabetes, Athens
Relationship of autoantibodies to glutamic acid decarboxylase (GADA) to deterioration of glycamic control assessed by therapy progression in latent autoimmune diabetes in adults (LADA) in the UKPDS
Clark A, Desai M, Cull CA, Horton VA, Christie MR, Bingley PJ, Bonifacio E, Levy JC, Holman RR
Diabetologia 2005;48:Suppl 1:A86
[Abstract]

41st Annual Meeting of the European Association for the Study of Diabetes, Athens
Genotype and beta cell response to therapy in a large type 2 diabetic cohort
Powell BL, Stratton IM, Holman RR, McCarthy MI
Diabetologia 2005;48:Suppl 1:A101-A102
[Abstract]

Diabetes UK Annual Professional Conference, Glasgow
AFORRD: a multi-centre trial evaluating potential cardiovascular risk reduction in patients with type 2 diabetes randomised in a factorial design to atorvastatin and/or omega-3 polyunsaturated fatty acids
Farmer AJ,Neil HAW, Holman RR
Diabetic Medicine 2005;22:S2:63
[Abstract]